Merck COVID-19 pill

Naeem Aslam Zaye Capital Markets

Merck made headlines on Friday when it revealed that molnupiravir, a drug in the research and development phase, could be used by consumers in pill form to fight Covid 19. On this project, Merck is collaborating with a privately held company called Ridgeback Biotherapeutics. If the company is successful in this endeavor, it will be the first to bring a coronavirus-specific antiviral pill to market. What distinguishes this drug from others is that other drugs must be used under strict supervision in hospitals, whereas this will most likely be available over the counter in pharmacies. According to data, the medication reduced the risk of death or hospitalization by a whopping 50%.

As soon as this news hit the market, Merck's stock price rose 8.4% to $81.40, its highest level in nearly five years. The drug's value could range between $1 billion and $10 billion, depending on its side effects and efficacy.

In Friday’s session, the Dow Jones Industrial Average rose 1.43%, and the S&P 500 index jumped 1.15%. The Nasdaq, the tech-savvy index, grew 0.82%, and the Russell 2000, the small-cap index, surged 1.69%.

Author

Naeem Aslam

Zaye Capital Markets

Based in London, Naeem Aslam is the co-founder of CompareBroker.io and is well-known on financial TV with regular contributions on Bloomberg, CNBC, BBC, Fox Business, France24, Sky News, Al Jazeera and many other tier-one media across the globe.

EUR/USD hits two-day highs near 1.1820

EUR/USD picks up pace and reaches two-day tops around 1.1820 at the end of the week. The pair’s move higher comes on the back of renewed weakness in the US Dollar amid growing talk that the Fed could deliver an interest rate cut as early as March. On the docket, the flash US Consumer Sentiment improves to 57.3 in February.

GBP/USD reclaims 1.3600 and above

GBP/USD reverses two straight days of losses, surpassing the key 1.3600 yardstick on Friday. Cable’s rebound comes as the Greenback slips away from two-week highs in response to some profit-taking mood and speculation of Fed rate cuts. In addition, hawkish comments from the BoE’s Pill are also collaborating with the quid’s improvement.

Gold climbs further, focus is back to 45,000

Gold regains upside traction and surpasses the $4,900 mark per troy ounce at the end of the week, shifting its attention to the critical $5,000 region. The move reflects a shift in risk sentiment, driving flows back towards traditional safe haven assets and supporting the yellow metal.

Crypto Today: Bitcoin, Ethereum, XRP rebound amid risk-off, $2.6 billion liquidation wave

Bitcoin edges up above $65,000 at the time of writing on Friday, as dust from the recent macro-triggered sell-off settles. The leading altcoin, Ethereum, hovers above $1,900, but resistance at $2,000 caps the upside. Meanwhile, Ripple has recorded the largest intraday jump among the three assets, up over 10% to $1.35.

Three scenarios for Japanese Yen ahead of snap election

The latest polls point to a dominant win for the ruling bloc at the upcoming Japanese snap election. The larger Sanae Takaichi’s mandate, the more investors fear faster implementation of tax cuts and spending plans.

XRP rally extends as modest ETF inflows support recovery

Ripple is accelerating its recovery, trading above $1.36 at the time of writing on Friday, as investors adjust their positions following a turbulent week in the broader crypto market. The remittance token is up over 21% from its intraday low of $1.12.